Suppr超能文献

甲状腺自身免疫与甲状腺功能正常女性的 IVF/ICSI 结局:系统评价和荟萃分析。

Thyroid autoimmunity and IVF/ICSI outcomes in euthyroid women: a systematic review and meta-analysis.

机构信息

Faculty of Medicine, The University of Queensland, Brisbane, Queensland, Australia.

QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia.

出版信息

Reprod Biol Endocrinol. 2020 Nov 25;18(1):120. doi: 10.1186/s12958-020-00671-3.

Abstract

BACKGROUND

Thyroid autoimmunity (TAI) - the presence of anti-thyroid peroxidase and/or anti-thyroglobulin antibodies - affects 8-14% of reproductively-aged women. It is hotly debated whether TAI adversely affects IVF/ICSI outcomes. This systematic review and meta-analysis evaluated the relationship between thyroid autoimmunity (TAI) and IVF/ICSI outcomes, both overall and amongst euthyroid women of known age using strict criteria for grouping pregnancy outcomes.

METHODS

The review was registered with PROSPERO: CRD42019120947. Searches were undertaken in MEDLINE, EMBASE, Web of Science and Cochrane Database from Inception-March 2020. Primary outcomes were clinical pregnancy rate, clinical miscarriage rate, biochemical pregnancy loss, livebirth rate per-cycle and live birth rate per clinical pregnancy (CP).

RESULTS

14 studies were included in the meta-analysis. Compared with women who tested negative for thyroid autoantibodies (TAI-), there was no significant difference in clinical pregnancy rate overall (OR 0.86; 95%CI [0.70, 1.05]; P = 0.14; 11 studies; I = 29.0%), or in euthyroid women (OR 0.88; 95%CI [0.69, 1.12]; P = 0.29; 10 studies; I = 32.0%). There was also no significant difference in clinical miscarriage rate overall (OR 1.04; 95%CI [0.52, 2.07]; P = 0.908; 8 studies; I = 53%), or in euthyroid women (OR 1.18; 95%CI [0.52, 2.64]; P = 0.69; 7 studies; I = 54%). There was no significant difference in biochemical pregnancy loss (OR 1.14; 95%CI [0.48, 2.72]; P = 0.769; 4 studies; I2 = 0.0%), live birth rate per cycle (OR 0.84; 95%CI [0.67, 1.06]; P = 0.145; I = 1.7%), live birth rate per clinical pregnancy (OR 0.67; 95%CI [0.28, 1.60]; P = 0.369; I = 69.2%), both overall and in euthyroid women as all studies included consisted of euthyroid women only. There was also no significant difference in number of embryos transferred, number of oocytes retrieved, mean maternal age or TSH levels overall or in euthyroid women.

CONCLUSION

The findings of the present study suggest that thyroid autoimmunity has no effect on pregnancy outcomes in euthyroid women alone, or in euthyroid women and women with subclinical hypothyroidism.

摘要

背景

甲状腺自身免疫(TAI)-抗甲状腺过氧化物酶和/或抗甲状腺球蛋白抗体的存在-影响 8-14%的生殖年龄妇女。TAI 是否会对试管婴儿/卵胞浆内单精子注射(ICSI)结果产生不利影响存在激烈争议。本系统评价和荟萃分析评估了甲状腺自身免疫(TAI)与试管婴儿/卵胞浆内单精子注射(ICSI)结果之间的关系,包括整体和在使用严格标准分组妊娠结局的已知年龄的甲状腺功能正常女性中。

方法

该综述在 PROSPERO 中进行了注册:CRD42019120947。从开始到 2020 年 3 月,在 MEDLINE、EMBASE、Web of Science 和 Cochrane 数据库中进行了搜索。主要结局是临床妊娠率、临床流产率、生化妊娠丢失率、每周期活产率和每临床妊娠活产率(CP)。

结果

14 项研究纳入荟萃分析。与甲状腺自身抗体(TAI)阴性的女性相比,整体临床妊娠率无显著差异(OR 0.86;95%CI [0.70,1.05];P=0.14;11 项研究;I=29.0%),或在甲状腺功能正常的女性中(OR 0.88;95%CI [0.69,1.12];P=0.29;10 项研究;I=32.0%)。整体临床流产率也无显著差异(OR 1.04;95%CI [0.52,2.07];P=0.908;8 项研究;I=53%),或在甲状腺功能正常的女性中(OR 1.18;95%CI [0.52,2.64];P=0.69;7 项研究;I=54%)。生化妊娠丢失率也无显著差异(OR 1.14;95%CI [0.48,2.72];P=0.769;4 项研究;I2=0.0%),每周期活产率(OR 0.84;95%CI [0.67,1.06];P=0.145;I=1.7%),每临床妊娠活产率(OR 0.67;95%CI [0.28,1.60];P=0.369;I=69.2%),整体和甲状腺功能正常的女性中均无显著差异,因为所有研究均仅包括甲状腺功能正常的女性。胚胎移植数量、卵母细胞采集数量、平均产妇年龄或 TSH 水平在整体或甲状腺功能正常的女性中也无显著差异。

结论

本研究结果表明,甲状腺自身免疫对甲状腺功能正常女性或甲状腺功能正常和亚临床甲状腺功能减退女性的妊娠结局没有影响。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/84f6/7687721/348d2f3b2abe/12958_2020_671_Fig1_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验